Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 12/20 | 1.00 |
| ▸ | ESR2 | Q92731 | 10/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | AR | P10275 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | HTR6 | P50406 | 1/20 | 1.00 |
| ▸ | ESRRG | P62508 | 1/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.80 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | TYR | P14679 | 2/20 | 0.68 |
| ▸ | SHBG | P04278 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bisphenol A SCHEMBL15062 | 1.00 | ESR1 (1.00) | ESR1ESR2CYP3A4HPGDHSD17B10 | |
| Bisphenol A SCHEMBL278218 | 1.00 | ESR1 (1.00) | ESR1ESR2CYP3A4HPGDHSD17B10 | |
| Bisphenol A SCHEMBL8051951 | 1.00 | ESR1 (1.00) | ESR1ESR2CYP3A4HPGDHSD17B10 | |
| Bisphenol A SCHEMBL8058731 | 1.00 | ESR1 (1.00) | ESR1ESR2CYP3A4HPGDHSD17B10 | |
| SCHEMBL15868669 | 1.00 | ESR1 (1.00) | ESR1ESR2CYP3A4HPGDHSD17B10 | |
| SCHEMBL27996 | 1.00 | ESR1 (1.00) | ESR1ESR2CYP3A4HPGDHSD17B10 | |
| Bisphenol A SCHEMBL9774987 | 1.00 | ESR1 (1.00) | ESR1ESR2CYP3A4HPGDHSD17B10 | |
| Bisphenol A SCHEMBL31267162 | 1.00 | ESR1 (1.00) | ESR1ESR2CYP3A4HPGDHSD17B10 | |
| Bisphenol A SCHEMBL7169162 | 0.97 | ESR1 (0.94) | ESR1ESR2CYP3A4HPGDHSD17B10 | |
| Bisphenol A SCHEMBL11798493 | 0.97 | ESR1 (0.94) | ESR1ESR2CYP3A4HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10167377-B2 | Phosphorus containing epoxy compounds and compositions therefrom | FRX POLYMERS, INC. (US) | 2019-01-01 | — | — | US | disclosed |
| US-10077354-B2 | Epoxy compositions | FRX POLYMERS, INC. (US) | 2018-09-18 | — | — | US | disclosed |
| US-9550911-B2 | Fluorinated alkyl ether epoxy resin compositions and applications thereof | The United States of America as represented by the Administrtor of the National Aeronautics and Space Administration (US) | 2017-01-24 | — | — | US | disclosed |
| EP-3114170-A1 | EPOXY COMPOSITIONS | FRX Polymers, Inc. (US) | 2017-01-11 | — | — | EP | disclosed |
| US-20150344748-A1 | Fluorinated Alkyl Ether Epoxy Resin Compositions and Applications Thereof | UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION | 2015-12-03 | — | — | US | disclosed |
| EP-2948464-A1 | PHOSPHORUS CONTAINING EPOXY COMPOUNDS AND COMPOSITIONS THEREFROM | FRX Polymers, Inc. (US) | 2015-12-02 | — | — | EP | disclosed |
| WO-2015134600-A1 | EPOXY COMPOSITIONS | FRX POLYMERS, INC. (US) | 2015-09-11 | — | — | WO | disclosed |
| US-20150252228-A1 | EPOXY COMPOSITIONS | FRX POLYMERS, INC. (US) | 2015-09-10 | — | — | US | disclosed |
| US-20150252175-A1 | EPOXY COMPOSITIONS | FRX POLYMERS, INC. (US) | 2015-09-10 | — | — | US | disclosed |
| WO-2014116669-A1 | PHOSPHORUS CONTAINING EPOXY COMPOUNDS AND COMPOSITIONS THEREFROM | FRX POLYMERS, INC. (US) | 2014-07-31 | — | — | WO | disclosed |
| US-20050208416-A1 | Branched polyarylene ethers and processes for the preparation thereof | XEROX CORPORATION | 2005-09-22 | — | — | US | disclosed |
| US-20050165201-A1 | Epoxidizing an alpha-halohydrin intermediate from a halide substitution-deesterification of an alpha -hydroxy ester derivative obtained by the coupling reaction of a phenol and a glycidyl ester | BORIACK CLINTON J (US) | 2005-07-28 | — | — | US | disclosed |
| US-20050033094-A1 | Process for preparing aryl allyl ethers | BORIACK CLINTON J (US) | 2005-02-10 | — | — | US | disclosed |
| US-20040049004-A1 | Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom | THE DOW CHEMICAL COMPANY | 2004-03-11 | — | — | US | disclosed |
| US-20040024263-A1 | Process for preparing aryl allyl ethers | BORIACK CLINTON J (US) | 2004-02-05 | — | — | US | disclosed |
| US-6646102-B2 | Epoxidizing an alpha - halohydrin intermediate produced from a halide substitution of an alpha -dihydroxy derivative which has been obtained by a dihydroxylation reaction of an aryl allyl ether, oxidation catalysts | DOW GLOBAL TECHNOLOGIES INC. | 2003-11-11 | — | — | US | disclosed |
| US-20030149219-A1 | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom | BORIACK CLINTON J (US) | 2003-08-07 | — | — | US | disclosed |
| US-20030105268-A1 | Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2003-06-05 | — | — | US | disclosed |
| US-6534621-B2 | Epoxidizing an alpha-halohydrin intermediate produced from an in situ halide substitution-deesterification of an alpha-hydroxy ester derivative | DOW GLOBAL TECHNOLOGIES INC. | 2003-03-18 | — | — | US | disclosed |
| US-20020045707-A1 | Process for manufacturing a hydroxyester derivative intermediate and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2002-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024263-A1 | Process for preparing aryl allyl ethers | PICALM, AP2M1, AP1M1 | ESR1 33/4885ESR2 197/4885CYP3A4 73/4885 |
| US-20050033094-A1 | Process for preparing aryl allyl ethers | PICALM, AP2M1, AP1M1 | ESR1 33/4885ESR2 197/4885CYP3A4 73/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.